Perspectives Article

Perspectives Article

Keryanne Gagnon
Targeting TMEM16F‑Driven Membrane Remodeling: A Promising Strategy for Broad-Spectrum Antiviral Development
August 4, 2026
Sadaf Hamidi
Targeting TMEM41B Lipid Remodeling: A Potential Broad-Spectrum Host-Directed Approach against Global Viral Threats
August 4, 2026
Houria Afshar Moghaddam
Targeting Endolysosomal Two-Pore Channel 2 (TPC2) as a Host-Directed Antiviral Strategy Against RNA and DNA Viruses of Global Health Concern
August 4, 2026
Marcus Liang
Hijacking the Hijackers: Targeting Coat Protein Complex I (COPI)-Mediated Retrograde Transport for Broad-Spectrum Antivirals
August 4, 2026
Helen Azer
HSP70 as a Host-Directed Target for Broad-Spectrum Antivirals Against Emerging WHO Priority Viruses
August 4, 2026
Annalise Wong
One Drug Many Bugs: Fatty Acid Synthase as a Broad-Spectrum Host-Directed Antiviral Target
August 4, 2026
Eknoor Toor
Exploring Mitochondrial Regulatory Pathways and Apoptotic Signaling as Host-Directed Targets for Broad-Spectrum Antivirals
August 4, 2026
Savitha Singarajan
The Secret Viral Highway: Hijacking Tunnelling Nanotubes to Hijack Viral Transmission
August 25, 2025
Charles Kim
Nipah Virus: Human Immune Responses, Transmission Mechanisms, and Vaccine Development
August 25, 2025
Andrew Huang
Nuclear and Extracellular Lipid Droplets as Novel Players in Viral Infection and Broad-Spectrum Antiviral Strategies
August 25, 2025
Steven Chen
Two-pore Channel Protein 2 as a Novel Broad-Spectrum Host-Acting Antiviral Target
August 25, 2025
Vivian Tan
SUMOylation of Viral Proteins: A Promising Host-Directed Antiviral Strategy
August 25, 2025
Chung Wah Cyrus Yong
The Potential of Lipid Carriers With Sialidase mRNA Payloads as Broad-Spectrum Host-Directed Antivirals
August 25, 2025
Wan Yi Liang
The Potential of STING Modulation as Broad-spectrum Host Antiviral Therapeutics for RNA Viruses
August 25, 2025
Michelle Tong
Blue-sky vision: Targeting microRNA-21 as a Broad-Spectrum Antiviral Approach
August 25, 2025
Delphine Zhou
Targeting Nuclear Lipid Droplets: Expanding Host-Directed Antiviral Therapies for Emerging Viral Threats
August 25, 2025
Sina Safaeian
Assessing the Developing Risk of Viral Bioterrorism: Implications and Immunological Interventions
August 30, 2024
Rachel Leong
Potential Pathophysiological Mechanisms Explaining the Association Between Viral Infections and Depression
August 30, 2024
Luiza Lopes Pontual
The Current State and Future Directions of Therapeutics for SARS-CoV-2 Variants of Concern
August 30, 2024
Jinny Choi
Analyzing the biological mechanisms of CCL11 in cognitive impairments following COVID-19 infection and populations at greater risk
August 18, 2023
Sana Samadi
The Road Less Traveled: Advancing SARS-CoV-2 research with the exploration of non-structural proteins using organoid models
August 18, 2023
Mark Josef Huang
Models and theories investigating the interactions of SARS-CoV-2 infection with the blood-brain barrier
August 18, 2023
Zee Muradi
Circulating miRNAs as biomarkers for SARS-CoV-2 and long COVID: Mechanisms and prognostic potential
August 18, 2023
Iris Zhou
Are the newly authorized antiviral drug treatment for non-severe COVID-19 may change the course of the pandemic?
August 18, 2023
Loujain Bilal
Syncytia Formation: A trademark of severe SARS-CoV-2 infection and a potential target for novel drug therapies
August 18, 2023
Azraa Banka
Non-structural protein 6: a hallmark of SARS-CoV-2 disease progression and its connection to lipid droplets
August 18, 2023
Tahia Ibtisam
Effectiveness of currently authorized vaccines against SARS-CoV-2 variants of concern and the future of COVID-19 vaccines
July 13, 2022
Kristi Lichimo
3CLpro: The discovery of host cell substrates and its relevance as a drug target for SARS-CoV-2 variants of concern
July 13, 2022
Garshana Rajkumar
SARS-CoV-2 potential pathways of neuroinvasion and the role of astrocytes in neuroinvasion
July 13, 2022
Josie Setiawan
Evaluating the future of monoclonal antibody therapy for SARS-CoV-2
July 13, 2022